Recent studies have shown that approximately 10% of PTCs have a TERT gene mutation, whereas 40% of poorly differentiated thyroid cancers and 70% of ATCs have a TERT mutation (7–9). The gene discussed is TERT; the disease is thyroid gland carcinoma.